ShandongShandong Cancer Hospital and Institute
ShandongShandong Cancer Hospital and Institute
Jinan, Shandong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular | hepatocellular carcinoma | Not yet recruiting | Phase 2 | 2026-01-20 | NCT07352007 |